NORACT is an open, multicenter, randomized controlled study with an embedded internal pilot trial.
On this site you will find information on the organization of the pilot trial and the full trial.
NORACT is an open, multicenter, randomized controlled study with an embedded internal pilot trial.
On this site you will find information on the organization of the pilot trial and the full trial.
Designed to evaluate the number of eligible participants and the feasibility and acceptability of the intervention.
Women in whom the clinician has equipoise as to whether an elective vaginal or abdominal cerclage will be the best intervention to prevent preterm birth.
Examples of women who could participate in the study
History of emergency/laboring cesarean section followed by a spontaneous singleton late miscarriage or PTB from 14+0 to 28+0* weeks
History with a prior elective vaginal cerclage placement but nonetheless a spontaneous late miscarriage or PTB between 14+0 and 28+0* weeks
History of a prior emergency cerclage with delivery between 14+0 and 28+0* weeks
Any conization and a short pre-pregnancy cervix (e.g. short ectocervix with inspection or below 15-20 mm with ultrasound)
History of one or more deliveries GA 16+0 to 28+0 weeks and a clinical diagnosis of cervical insufficiency
History of three or more deliveries GA 16+0 to 36+6 weeks
Lea Kirstine Hansen
MD., Ph.D-student
Dept. of obstetrics and gynecology
Aarhus University Hospital
auh.noract@rm.dk
+45 51 72 45 64
Dept. of obstetrics and gynecology
Aarhus University Hospital
Palle Juul-Jensens Boulevard 99
8200 Aarhus N